Respiratory Trials·org

Occupational & environmental · Air pollution and mortality

MCC-652 time-series analysis

Ambient Particulate Air Pollution and Daily Mortality in 652 Cities

MCC-652 trial design and results
Design Time-series analysis across 652 cities in 24 countries and regions
Treatment Higher ambient particulate concentration
Control Lower ambient particulate concentration
Population Daily mortality records from 652 cities worldwide
Follow-up Varies by city, multiple decades of daily records
Primary endpoint Association between short-term particulate exposure and daily all-cause mortality
Result An increase of 10 µg/m3 in the 2-day moving average of PM10 was associated with a 0.44% increase in daily all-cause mortality (95% CI 0.39 to 0.50), with corresponding increases in cardiovascular and respiratory mortality. Independent associations were seen for both PM10 and PM2.5.
Secondary endpoints Cardiovascular mortality, respiratory mortality, concentration-response shape

Our data show independent associations between short-term exposure to PM10 and PM2.5 and daily all-cause, cardiovascular, and respiratory mortality in more than 600 cities across the globe.

The trial authors, in the published abstract

How it has aged

The scale is what makes it hard to argue with: 652 cities, consistent associations, no evidence of a safe threshold. A 0.44% increase sounds trivial until it is applied to every death in every city every day. It is the evidential basis for air quality standards being tightened rather than met.

Publications

Ambient Particulate Air Pollution and Daily Mortality in 652 Cities

Liu C, Chen R, Sera F, et al. Ambient Particulate Air Pollution and Daily Mortality in 652 Cities. N Engl J Med 2019 Aug 22;381(8):705-715.

  • 0.44% increase in daily all-cause mortality per 10 µg/m3 of PM10
  • Independent associations for PM10 and PM2.5
  • Consistent across 652 cities in 24 countries